295 related articles for article (PubMed ID: 32407843)
1. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
[TBL] [Abstract][Full Text] [Related]
2. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
[TBL] [Abstract][Full Text] [Related]
3. ZNF677 downregulation by promoter hypermethylation as a driver event through gastric tumorigenesis.
Bidar N; Rezaei T; Amini M; Jebelli A; Mokhtarzadeh A; Baradaran B
Exp Mol Pathol; 2021 Aug; 121():104663. PubMed ID: 34171355
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
Hu G; Qin L; Zhang X; Ye G; Huang T
Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
[TBL] [Abstract][Full Text] [Related]
5. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.
Chen X; Lin Z; Xue M; Si J; Chen S
PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
7. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
[TBL] [Abstract][Full Text] [Related]
8. A methylation-driven gene panel predicts survival in patients with colon cancer.
Peng Y; Zhao J; Yin F; Sharen G; Wu Q; Chen Q; Sun X; Yang J; Wang H; Zhang D
FEBS Open Bio; 2021 Sep; 11(9):2490-2506. PubMed ID: 34184409
[TBL] [Abstract][Full Text] [Related]
9. GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60.
Zhou C; Pan R; Li B; Huang T; Zhao J; Ying J; Duan S
Future Oncol; 2019 Apr; 15(11):1279-1289. PubMed ID: 30924352
[TBL] [Abstract][Full Text] [Related]
10. Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer.
Ling ZQ; Lv P; Lu XX; Yu JL; Han J; Ying LS; Zhu X; Zhu WY; Fang XH; Wang S; Wu YC
PLoS One; 2013; 8(6):e67195. PubMed ID: 23826230
[TBL] [Abstract][Full Text] [Related]
11. Site-Specific Hypermethylation of SST 1stExon as a Biomarker for Predicting the Risk of Gastrointestinal Tract Cancers.
Dai X; Sun X; Wu Y; Lv Z; Yu Z; Yuan Y; Sun L
Dis Markers; 2022; 2022():4570290. PubMed ID: 35242243
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment.
Llorca-Cardeñosa MJ; Fleitas T; Ibarrola-Villava M; Peña-Chilet M; Mongort C; Martinez-Ciarpaglini C; Navarro L; Gambardella V; Castillo J; Roselló S; Navarro S; Ribas G; Cervantes A
Oncotarget; 2016 Sep; 7(39):63424-63436. PubMed ID: 27566570
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer.
Yuan R; Wang G; Xu Z; Zhao H; Chen H; Han Y; Wang B; Zhou J; Hu H; Guo Z; Shen H; Xue X
Anticancer Agents Med Chem; 2016; 16(9):1093-100. PubMed ID: 26179261
[TBL] [Abstract][Full Text] [Related]
15. Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer.
Wang N; Sui F; Ma J; Su X; Liu J; Yao D; Shi B; Hou P; Yang Q
Arch Med Res; 2016 May; 47(4):285-92. PubMed ID: 27664488
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of
Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
[TBL] [Abstract][Full Text] [Related]
17. DERL3 functions as a tumor suppressor in gastric cancer.
Li Y; Liu H; Chen H; Shao J; Su F; Zhang S; Cai X; He X
Comput Biol Chem; 2020 Feb; 84():107172. PubMed ID: 31862624
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
19. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S
Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954
[TBL] [Abstract][Full Text] [Related]
20. [Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium].
Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):510-3. PubMed ID: 18069630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
